Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;52(3):935-944.
doi: 10.1007/s15010-023-02139-z. Epub 2023 Dec 19.

Clinical correlates of circulating small dense low-density lipoproteins in acute infective endocarditis

Filomena Boccia  1 , Domenico Iossa  2   3 , Silvia Leonardi  4 , Anna Maria Peluso  1 , Lorenzo Bertolino  2 , Fabian Patauner  2 , Emilio Palmieri  1 , Rita Boenzi  4 , Rosa Zampino  1   3 , Emanuele Durante-Mangoni  5   6   7 ; Monaldi Hospital Cardiovascular Infection Study Group
Collaborators, Affiliations

Clinical correlates of circulating small dense low-density lipoproteins in acute infective endocarditis

Filomena Boccia et al. Infection. 2024 Jun.

Abstract

Background and aim: Infective endocarditis (IE) is a complex thrombo-inflammatory disorder, the pathogenesis of which involves a multifaceted interplay between vascular damage and bacterial virulence factors. This study aimed to assess the prognostic role of small dense low-density lipoprotein (sdLDL) cholesterol in patients with IE and its correlation with various disease-related features.

Methods: A cohort of 198 patients with definite IE was included in this study. Clinical, laboratory, and echocardiographic parameters were meticulously analyzed, with a specific focus on comorbidities. sdLDL levels were measured using stored plasma samples obtained upon admission during the acute phase of the disease.

Results: The median level of sdLDL was 24 mg/dL [with an interquartile range of 17.9-35.2 mg/dL], and this value showed a statistically significant positive correlation with LDL/HDL cholesterol and triglycerides (p < 0.01 for all). Furthermore, a remarkable inverse correlation between C-reactive protein and D-dimer levels was observed (p < 0.0001). Univariate analysis revealed that patients with sdLDL levels ≤ 24 mg/dL had 2.75 times higher odds of in-hospital mortality (95% Confidence Interval:1.08-6.98, p = 0.031). In addition, nonsurvivors had significantly lower median sdLDL levels (19.7 vs. 26.0 mg/dL, p = 0.041). Lower sdLDL levels were also associated with embolic complications, larger vegetation size, and positive blood cultures for Staphylococci (p = 0.019, p = 0.022, and p < 0.001, respectively).

Conclusions: Low circulating sdLDL levels in the acute phase of IE were significantly correlated with unfavorable clinical outcomes. These results suggest that the sdLDL level may serve as an important marker of disease severity in IE and may represent a link between vascular damage, embolic complications, and disease progression.

Keywords: Biomarkers; Heart valve disease; Lipids; Mortality.

PubMed Disclaimer

References

    1. Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019;40:3222–33. - DOI - PubMed
    1. Hubers SA, DeSimone DC, Gersh BJ, Anavekar NS. Infective endocarditis: a contemporary review. Mayo Clin Proc. 2020;95:982–97. https://doi.org/10.1016/j.mayocp.2019.12.008 . - DOI - PubMed
    1. Strange JE, Østergaard L, Køber L, Bundgaard H, Iversen K, Voldstedlund M, Gislason GH, Olesen JB, Fosbøl EL. Patient characteristics, microbiology, and mortality of infective endocarditis after transcatheter aortic valve implantation. Clin Infect Dis. 2023. https://doi.org/10.1093/cid/ciad431 . - DOI - PubMed - PMC
    1. Hidalgo-Tenorio C, Sadyrbaeva-Dolgova S, Enríquez-Gómez A, Muñoz P, Plata-Ciezar A, Miró JM, Alarcón A, Martínez-Marcos FJ, Loeches B, Eschiruela-Vidal F, Vinuesa D, Herrero C, Badia-Martí C, Arenas MDM, Vázquez EG, de Las-Revillas FA, Pasquau J, EN-DALBACEN Study Group. EN-DALBACEN 2.0 cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci. Int J Antimicrob Agents. 2023. https://doi.org/10.1016/j.ijantimicag.2023.106918 . - DOI - PubMed
    1. Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, Popescu BA, Prendergast B, Tornos P, Sadeghpour A, Oliver L, Vaskelyte JJ, Sow R, Axler O, Maggioni AP, Lancellotti P, EURO-ENDO Investigators. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019;40:3222–32. https://doi.org/10.1093/eurheartj/ehz620 . - DOI - PubMed

LinkOut - more resources